Dafne is an Associate Business Development Director in the Technology Development & Licensing team.

Dafne is responsible for building new business opportunities in the Life Science space, fostering new partnerships with industry, identifying new market trends, and developing strategic plans to accelerate the route to market while maximizing the societal impact of Cambridge innovation.

She works closely with academics to transform their ideas into products by supporting their development and securing translational grant funding and investment.

She led commercial deals in the domain of stem cells technologies, diagnostics, medical devices and AI.

She has held senior positions in Healthcare in the areas of Commercialisation of Innovation, Market Intelligence and Business Strategy, and worked as an external consultant for several companies such as Roche, Novartis, Bayer, Merck Serono, Alexion, Takeda, Debiopharm International, Nestlé, and Medtronic.

Before joining Cambridge Enterprise, Dafne worked as Sn IP Manager at Cambridge University Hospitals NHS Foundation Trust.

Dafne obtained a PhD in Biology from the Institute Curie (Paris, France) and the University Paris XI (Paris, France).

Dafne joined Cambridge Enterprise in January 2017.